HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells from donors show promise against dangerous virus in vulnerable patients
Disease control Recruiting nowThis early-stage trial tests whether specially grown donor immune cells (T cells) can safely fight adenovirus infections in people with weakened immune systems, such as cancer patients. The study involves 16 participants and focuses on side effects and how well the cells control …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:24 UTC
-
Engineered T-Cells take on viruses in cancer patients: a new hope?
Disease control Recruiting nowThis early-stage trial tests whether specially designed immune cells (T-cells) can safely control serious viral infections in cancer patients whose immune systems are weakened by treatment. The cells are modified to target specific viruses like CMV, BK virus, or COVID-19. The stu…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
New combo therapy aims to prevent spine fractures in cancer patients
Disease control Recruiting nowThis study looks at whether adding a procedure called vertebroplasty (which strengthens broken spine bones) to radiation therapy can help prevent further spine fractures and improve outcomes in people whose cancer has spread to the spine. About 200 adults with spine metastases wi…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Could a simple mask help cancer patients avoid breathing tubes?
Disease control Recruiting nowThis study looks at whether using a mask to deliver air pressure (non-invasive ventilation) can help cancer patients with breathing failure avoid needing a breathing tube. About 256 adults with cancer and low oxygen levels will be randomly assigned to get either the mask or stand…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New hope for kids: drug may prevent dangerous virus after transplant
Disease control Recruiting nowThis study tests whether the antiviral drug letermovir can prevent cytomegalovirus (CMV) infection in children and teens after a stem cell transplant. About 105 participants aged 2 to 17 who are CMV-positive will receive letermovir to see if it lowers infection rates compared to …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Cord blood cells join fight against transplant complication
Disease control Recruiting nowThis early study tests whether adding special cells from donated umbilical cord blood to a standard drug (ruxolitinib) can better control severe graft-versus-host disease (GVHD) that hasn't responded to steroids. GVHD is a serious complication where donor immune cells attack the …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Double antiviral attack: new combo aims to knock out flu in vulnerable patients
Disease control Recruiting nowThis study tests whether combining two antiviral drugs, baloxavir and oseltamivir, works better than oseltamivir alone for treating severe flu in people who have had a stem cell transplant or have blood cancer. About 60 participants will be followed for 30 days to see if the comb…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could donor stem cells repair Chemo-Damaged hearts?
Disease control Recruiting nowThis early-stage trial tests whether donor bone marrow stem cells can help control heart failure in people whose hearts were weakened by a type of chemotherapy called anthracyclines. About 72 adults with reduced heart function will receive either standard care alone or standard c…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Cord blood stem cells could tame COVID lung crisis
Disease control Recruiting nowThis study tests whether infusions of stem cells from donated umbilical cord blood can help people with moderate to critical COVID-19 pneumonia. The stem cells are grown in a lab and given to reduce lung inflammation and improve breathing. About 70 adults with COVID-19 and relate…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope: immune drug tested in patients with both autoimmune disease and cancer
Disease control Recruiting nowThis study is for people who have both an autoimmune disorder (like rheumatoid arthritis, lupus, or multiple sclerosis) and advanced cancer that has spread or cannot be removed. It tests a drug called nivolumab, which helps the immune system fight cancer, given alone or with othe…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Radioactive antibody blasts cancer before stem cell rescue in High-Risk leukemia trial
Disease control Recruiting nowThis study tests a radioactive antibody (211At-BC8-B10) followed by a donor stem cell transplant for people with high-risk leukemia or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The antibody targets cancer cells and delivers radiation, then c…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Writing away worry: new study tests expressive writing for cancer survivors
Symptom relief Recruiting nowThis study looks at whether expressive writing can help cancer survivors cope with stress, especially during challenging events like the COVID-19 pandemic. About 414 adults diagnosed with cancer in the past 3 years will participate online from home. They will write about their th…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:17 UTC
-
Clot-busting drug may ease breathlessness in cancer patients with trapped lung fluid
Symptom relief Recruiting nowThis study tests if alteplase, a drug that dissolves blood clots, can help drain fluid from around the lungs and improve breathing in people with cancer. Participants have a tube in their chest that is not draining well. The study will compare alteplase to a placebo to see if it …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
Stickers and steps: new study tests Reward-Based exercise for kids with cancer
Symptom relief Recruiting nowThis study looks at whether a special exercise program called TEAM Me can help children, teens, and young adults with cancer stay active while they are in the hospital for a stem cell transplant. The program uses tokens like stickers that can be traded for rewards to encourage wa…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
Brain training tackles chemo nerve pain
Symptom relief Recruiting nowThis study tests whether combining a nerve pain drug (duloxetine) with neurofeedback—a therapy that teaches you to change your own brain waves—can better relieve chemotherapy-induced nerve damage than either treatment alone. About 380 adults with nerve pain from past chemo will b…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
Massive study tracks proton therapy side effects to improve future cancer care
Knowledge-focused Recruiting nowThis study is gathering information on side effects from proton therapy in 5,000 adults with various cancers. Researchers will collect detailed treatment and toxicity data to better understand and predict short- and long-term side effects. The goal is to improve future patient ca…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:26 UTC
-
Pandemic's hidden toll on young cancer survivors revealed
Knowledge-focused Recruiting nowThis study looks at how the COVID-19 pandemic affected the emotional, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. Researchers will survey 600 participants to understand their stress and challenges during the pandem…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:23 UTC
-
2000 volunteers help scientists create a master reference for cancer blood tests
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people—some with cancer, some without—to create a blinded reference set. Researchers will use these samples to evaluate how well new blood tests can detect many types of cancer early. The goal is to improve the accuracy of mu…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated May 26, 2026 04:16 UTC
-
Scientists seek volunteers to unlock secrets of the immune system
Knowledge-focused Recruiting nowThis study collects blood, tissue, and bone marrow samples from people with cancer or blood disorders, as well as healthy volunteers. The goal is to learn how the immune system works and how it changes with different treatments like immunotherapy. No direct treatment is given; th…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC
-
Researchers track Real-World results of CAR-T and radiation combo
Knowledge-focused Recruiting nowThis study gathers information from 100 adults with blood cancers who receive CAR-T therapy and/or radiation as part of their standard care. The goal is to learn how to better choose patients, timing, and doses for these treatments. No new drugs or procedures are being tested—onl…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC
-
Blood cancer Patients' memory after brain radiation under study
Knowledge-focused Recruiting nowThis study tracks memory and thinking changes in 100 adults with blood cancers (like lymphoma or leukemia) who receive whole brain radiation. Researchers will test cognitive skills over time to understand the treatment's effects on the brain. The goal is to learn more, not to tes…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC
-
Pandemic pivot: lung doctors share how COVID-19 reshaped their practice
Knowledge-focused Recruiting nowThis study surveys 250 lung specialists across the U.S. to learn how the COVID-19 pandemic changed the way they perform procedures, staff their teams, and run their clinics. The goal is to understand what worked and where to focus future research so hospitals can better handle th…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC
-
Video mentoring brings better cancer care to remote regions
Knowledge-focused Recruiting nowThis study looks at whether a video-based mentoring program (Project ECHO) can help doctors in underserved areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia provide better palliative care to patients with advanced cancer. About 312 patients and their caregivers wi…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:11 UTC
-
Lung disease after transplant: are viruses to blame?
Knowledge-focused Recruiting nowThis study watches 250 people who had a donor stem cell transplant to see if respiratory viruses lead to a lung condition called bronchiolitis obliterans syndrome (BOS). Participants use a simple home device to check their lung function regularly. The goal is to learn how viruses…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
Doctors unite to create universal prostate cancer report card
Knowledge-focused Recruiting nowThis study brings together a panel of prostate cancer experts to agree on the most important information to include in medical reports. The goal is to create a standard way of reporting key data in electronic health records, helping doctors better manage patients from diagnosis t…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Gut bacteria could be key to better cancer therapy
Knowledge-focused Recruiting nowThis study looks at how the gut microbiome (the bacteria living in your digestive system) might influence how well cancer treatments work. Researchers at Mayo Clinic will collect samples from 3000 cancer patients undergoing therapy or stem cell transplants. The goal is to find li…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
Gene tests could unlock personalized cancer treatments for thousands
Knowledge-focused Recruiting nowThis study analyzes tumor tissue from up to 12,000 cancer patients to identify gene mutations. The goal is to match each patient with a clinical trial or therapy that targets their specific cancer type. Researchers will also build a database of mutations to improve future cancer …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC
-
Cancer drug side effects under the microscope
Knowledge-focused Recruiting nowThis study tracks side effects and treatment results in 170 advanced cancer patients receiving anti-VEGF therapy. Researchers want to see if certain side effects are linked to how well the cancer responds. The goal is to help doctors better predict outcomes and manage treatment.
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC